Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2006.12.024
Annals of Surgical Oncology 13:565-571 (2006)
© 2006 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poncelet, C.
Right arrow Articles by Daraï, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poncelet, C.
Right arrow Articles by Daraï, E.

Original Article

Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study

Christophe Poncelet, MD, PhD1,2, Raffaèle Fauvet, MD1, Joëlle Boccara, MD1 and Emile Daraï, MD, PhD1

1 Service de Gynécologie-Obstétrique, Hôpital Tenon, AP-HP, 4 Rue de la Chine, CancerEst, UFR Saint-Antoine, 75020 Paris VI, France
2 UFR SMBH Léonard De Vinci, Université Paris XIII, 93017 Bobigny Cedex, Paris, France

Correspondence: Address correspondence and reprint requests to: Emile Daraï, MD, PhD; E-mail: emile.darai{at}tnn.ap-hop-paris.fr.

Background: Fertility-sparing surgery for borderline ovarian tumors (BOT) is feasible and effective and does not seem to have a negative effect on survival. Specific data on the effect of cystectomy, and notably on recurrence, are lacking.

Methods: This was a French retrospective multicenter study of 313 women with stage I BOT treated from 1990 to 2000 in 13 specialized gynecological units and 1 cancer center. Diagnosis and staging were based on International Federation of Gynecology and Obstetrics (1989) criteria. Surgery consisted of cystectomy, unilateral salpingo-oophorectomy (USO), or bilateral salpingo-oophorectomy (BSO).

Results: After cystectomy, persistent BOT and benign ovarian cysts on the operated ovary were observed in 15% and 65% of patients, respectively. Mean follow-up did not differ among patients receiving the three types of surgery. The recurrences after cystectomy, USO, and BSO treatment were 30.3%, 11%, and 1.7%, respectively (P < .0001). Recurrences were more frequent after cystectomy than after USO (P = .0001) and BSO (P = .0001) and when intraoperative cyst rupture occurred (P = .04).

Conclusions: These results suggest that cystectomy for BOT is associated with a high risk of intraoperative cyst rupture and of recurrence compared with USO or BSO.

Key Words: Borderline ovarian tumors • Recurrence • Cystectomy • Persistent tumor • Salpingo-oophorectomy




This article has been cited by other articles:


Home page
Am Soc Clin Oncol Ed BookHome page
D. Yamada
The Role of Surgery in Ovarian Cancer Management
ASCO Educational Book, January 1, 2009; 2009(1): 302 - 307.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. N. Fader and P. G. Rose
Role of Surgery in Ovarian Carcinoma
J. Clin. Oncol., July 10, 2007; 25(20): 2873 - 2883.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society of Surgical Oncology.